Johannes R Kratz
Affiliation: University of California
- Genomic prognostic models in early-stage lung cancerJohannes R Kratz
Department of Surgery, University of California San Francisco Cancer Center, CA 94143 0128, USA
Clin Lung Cancer 10:151-7. 2009..An effort to develop a robust genomic model for use in the clinical setting should be prompted by encouraging results obtained by the use of a quantitative PCR-based genomic signature in the field of breast oncology...
- Cancer stem cells in lung tumorigenesisJohannes R Kratz
Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA
Ann Thorac Surg 89:S2090-5. 2010..Continued research in the field of lung cancer stem cell biology is vital, as ongoing efforts promise to yield new prognostic and therapeutic targets...
- Analytical validation of a practical molecular assay prognostic of survival in nonsquamous non-small cell lung cancerJohannes R Kratz
Thoracic Oncology Program, Department of Surgery, University of California, San Francisco, San Francisco, CA, USA
Diagn Mol Pathol 22:65-9. 2013....
- The role of stem cells in airway repair: implications for the origins of lung cancerMichael S Mulvihill
Thoracic Oncology Program, Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94115, USA
Chin J Cancer 32:71-4. 2013..The implications of a stem cell origin of lung cancer are reviewed, and the importance of ongoing research to identify novel therapeutic and prognostic targets is reiterated...
- Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2Kush M Parmar
Center for Excellence in Vascular Biology, Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
J Clin Invest 116:49-58. 2006..KLF2 therefore serves as a mechano-activated transcription factor important in the integration of multiple endothelial functions associated with regions of the arterial vasculature that are relatively resistant to atherogenesis...